Global Carrier Screening for Genetic Conditions Supply, Demand and Key Producers, 2026-2032
Description
The global Carrier Screening for Genetic Conditions market size is expected to reach $ 4895 million by 2032, rising at a market growth of 9.0% CAGR during the forecast period (2026-2032).
Carrier Screening for Genetic Conditions is a genetic testing approach used to determine whether an individual carries a gene variant associated with inherited disorders that may be passed on to offspring. Carriers typically do not show symptoms of the condition but can transmit the altered gene to their children, particularly in autosomal recessive or X-linked inheritance patterns. The screening is commonly performed before or during pregnancy to assess reproductive risk, support informed family planning decisions, and guide further diagnostic or counseling steps when both partners are identified as carriers of the same genetic condition.
This report studies the global Carrier Screening for Genetic Conditions demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Carrier Screening for Genetic Conditions, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Carrier Screening for Genetic Conditions that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Carrier Screening for Genetic Conditions total market, 2021-2032, (USD Million)
Global Carrier Screening for Genetic Conditions total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Carrier Screening for Genetic Conditions total market, key domestic companies, and share, (USD Million)
Global Carrier Screening for Genetic Conditions revenue by player, revenue and market share 2021-2026, (USD Million)
Global Carrier Screening for Genetic Conditions total market by Type, CAGR, 2021-2032, (USD Million)
Global Carrier Screening for Genetic Conditions total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Carrier Screening for Genetic Conditions market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Eurofins Scientific, Illumina, Labcorp, Quest Diagnostics, MedGenome, Myriad Genetics, Natera, OPKO Health, 23andMe, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Carrier Screening for Genetic Conditions market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Carrier Screening for Genetic Conditions Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Carrier Screening for Genetic Conditions Market, Segmentation by Type:
NGS
Whole Exome Sequencing
Others
Global Carrier Screening for Genetic Conditions Market, Segmentation by Screening Timing:
Preconception Screening
Prenatal Screening
Global Carrier Screening for Genetic Conditions Market, Segmentation by Screening Scope:
Single-condition Screening
Targeted multi-condition Screening
Global Carrier Screening for Genetic Conditions Market, Segmentation by Application:
Couple
Individual
Companies Profiled:
Thermo Fisher Scientific
Eurofins Scientific
Illumina
Labcorp
Quest Diagnostics
MedGenome
Myriad Genetics
Natera
OPKO Health
23andMe
Mayo Clinic Laboratories
Baylor Genetics
GeneDx
Fulgent Genetics
NxGen MDx
Sonic Genetics
Ambry Genetics
PreventionGenetics
DiaSorin
SYNLAB
BGI Genomics
Berry Genomics
Annaroad
Jiajian Medical Testing
Genesky
Weihansi Biomedical Technology
Key Questions Answered
1. How big is the global Carrier Screening for Genetic Conditions market?
2. What is the demand of the global Carrier Screening for Genetic Conditions market?
3. What is the year over year growth of the global Carrier Screening for Genetic Conditions market?
4. What is the total value of the global Carrier Screening for Genetic Conditions market?
5. Who are the Major Players in the global Carrier Screening for Genetic Conditions market?
6. What are the growth factors driving the market demand?
Carrier Screening for Genetic Conditions is a genetic testing approach used to determine whether an individual carries a gene variant associated with inherited disorders that may be passed on to offspring. Carriers typically do not show symptoms of the condition but can transmit the altered gene to their children, particularly in autosomal recessive or X-linked inheritance patterns. The screening is commonly performed before or during pregnancy to assess reproductive risk, support informed family planning decisions, and guide further diagnostic or counseling steps when both partners are identified as carriers of the same genetic condition.
This report studies the global Carrier Screening for Genetic Conditions demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Carrier Screening for Genetic Conditions, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Carrier Screening for Genetic Conditions that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Carrier Screening for Genetic Conditions total market, 2021-2032, (USD Million)
Global Carrier Screening for Genetic Conditions total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Carrier Screening for Genetic Conditions total market, key domestic companies, and share, (USD Million)
Global Carrier Screening for Genetic Conditions revenue by player, revenue and market share 2021-2026, (USD Million)
Global Carrier Screening for Genetic Conditions total market by Type, CAGR, 2021-2032, (USD Million)
Global Carrier Screening for Genetic Conditions total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Carrier Screening for Genetic Conditions market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Eurofins Scientific, Illumina, Labcorp, Quest Diagnostics, MedGenome, Myriad Genetics, Natera, OPKO Health, 23andMe, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Carrier Screening for Genetic Conditions market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Carrier Screening for Genetic Conditions Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Carrier Screening for Genetic Conditions Market, Segmentation by Type:
NGS
Whole Exome Sequencing
Others
Global Carrier Screening for Genetic Conditions Market, Segmentation by Screening Timing:
Preconception Screening
Prenatal Screening
Global Carrier Screening for Genetic Conditions Market, Segmentation by Screening Scope:
Single-condition Screening
Targeted multi-condition Screening
Global Carrier Screening for Genetic Conditions Market, Segmentation by Application:
Couple
Individual
Companies Profiled:
Thermo Fisher Scientific
Eurofins Scientific
Illumina
Labcorp
Quest Diagnostics
MedGenome
Myriad Genetics
Natera
OPKO Health
23andMe
Mayo Clinic Laboratories
Baylor Genetics
GeneDx
Fulgent Genetics
NxGen MDx
Sonic Genetics
Ambry Genetics
PreventionGenetics
DiaSorin
SYNLAB
BGI Genomics
Berry Genomics
Annaroad
Jiajian Medical Testing
Genesky
Weihansi Biomedical Technology
Key Questions Answered
1. How big is the global Carrier Screening for Genetic Conditions market?
2. What is the demand of the global Carrier Screening for Genetic Conditions market?
3. What is the year over year growth of the global Carrier Screening for Genetic Conditions market?
4. What is the total value of the global Carrier Screening for Genetic Conditions market?
5. Who are the Major Players in the global Carrier Screening for Genetic Conditions market?
6. What are the growth factors driving the market demand?
Table of Contents
179 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Carrier Screening for Genetic Conditions Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Screening Timing
- 7 Market Analysis by Screening Scope
- 8 Market Analysis by Application
- 9 Company Profiles
- 10 Industry Chain Analysis
- 11 Research Findings and Conclusion
- 12 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

